Comparison of articular cartilage repair with different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat model
Open Access
- 19 March 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Stem Cell Research & Therapy
- Vol. 5 (2), 39
- https://doi.org/10.1186/scrt427
Abstract
The present work was designed to explore the feasibility and efficacy of articular cartilage repair using composites of human umbilical cord blood derived mesenchymal stem cells (hUCB-MSCs) and four different hydrogels in a rat model. Full-thickness articular cartilage defects were created at the trochlear groove of femur in both knees of rats. Composites of hUCB-MSCs and four different hydrogels (group A, 4% hyaluronic acid; group B, 3% alginate:30% pluronic (1:1, v/v); group C, 4% hyaluronic acid: 3% alginate: 20% pluronic (2:1:1, v/v}; and group D, 4% hyaluronic acid:3% alginate:20% pluronic;chitosan (4:1:1:2, v/v).) were then transplanted into right knee defect in each study group (five rats/group). Left knees were transplanted with corresponding hydrogels without hUCB-MSCs as controls. At 16 weeks post-transplantation, degrees of cartilage repair were evaluated macroscopically and histologically using Masson’s Trichrome, safranin-O, Sirius red staining, and type-II collagen immunostaining. Overall, group A with 4% hyaluronic acid hydrogel resulted in superior cartilage repair grossly and histologically and achieved a cellular arrangement and collagen organization pattern mimicking adjacent uninjured articular cartilage. Immunostaining and safranin-O staining also revealed that group A displayed the largest areas of type II collagen staining. Sirius red staining revealed that the organization pattern of collagen bundles was more similar to normal cartilage in group A. No evidence of rejection was found. The results of this study suggest that hUCB-MSCs could be used to repair articular cartilage defects in vivo and that hyaluronic acid is an attractive hydrogel candidate for use in combination with hUCB-MSCs.Keywords
This publication has 58 references indexed in Scilit:
- In situ cross-linkable hyaluronan hydrogel enhances chondrogenesisJournal of Tissue Engineering and Regenerative Medicine, 2011
- Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug DeliveryJournal of Young Pharmacists, 2010
- Application of human umbilical cord blood-derived mesenchymal stem cells in disease modelsWorld Journal of Stem Cells, 2010
- Mesenchymal Stem Cell Differentiation in an Experimental Cartilage Defect: Restriction of Hypertrophy to Bone-Close NeocartilageStem Cells and Development, 2009
- Differential Maturation and Structure–Function Relationships in Mesenchymal Stem Cell- and Chondrocyte-Seeded HydrogelsTissue Engineering, Part A, 2009
- Influence of Three-Dimensional Hyaluronic Acid Microenvironments on Mesenchymal Stem Cell ChondrogenesisTissue Engineering, Part A, 2009
- The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitroImmunology, 2009
- Impact of Myocardial Infarct Proteins and Oscillating Pressure on the Differentiation of Mesenchymal Stem Cells: Effect of Acute Myocardial Infarction on Stem Cell DifferentiationThe International Journal of Cell Cloning, 2008
- Hydrogels for biomedical applicationsAdvanced Drug Delivery Reviews, 2001
- Hyaluronic AcidDrugs, 1994